Skip to main content
Glenmark Pharmaceuticals ltd logo

Glenmark Pharmaceuticals ltd — Investor Relations & Filings

Ticker · GLENMARK ISIN · INE935A01035 LEI · 335800WKECZXIIT9GK20 BSE.NS Manufacturing
Open in API
Filings indexed 1,034 across all filing types
Latest filing 2024-08-14 Regulatory Filings
Country IN India
Listing BSE.NS GLENMARK

About Glenmark Pharmaceuticals ltd

https://glenmarkpharma.com/

Glenmark Pharmaceuticals Ltd. is a research-driven global organization focused on the development, manufacturing, and marketing of generic, specialty, and over-the-counter medicines. The company maintains a specialized focus on therapeutic areas including dermatology, respiratory health, and oncology. It operates a robust research and development pipeline featuring New Chemical Entities (NCEs) and New Biological Entities (NBEs), supported by multiple global R&D centers. Its commercial footprint extends across North America, Europe, and emerging markets. The company is distinguished by its expertise in complex generics and its integrated approach to drug discovery and formulation development. Glenmark utilizes a network of advanced manufacturing facilities to deliver high-quality healthcare solutions globally, emphasizing innovation and accessibility in its product portfolio.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2024-08-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a formal invitation and announcement of an upcoming earnings call scheduled for August 16, 2024, regarding Glenmark Pharmaceuticals Ltd.'s Q1 FY 2024-25 results. It includes dial-in details and contact information but does not contain any financial data, analysis, or results itself. The document length is short (1976 characters) and serves as a notification rather than the actual earnings release or call transcript. Therefore, it fits the category of a Call Transcript (CT) announcement rather than the transcript itself, but since the transcript is not included, the best classification is a Call Transcript (CT) category as it is specifically about the earnings call event.
2024-08-05 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about an upcoming Board Meeting scheduled for August 14, 2024, to consider and approve the unaudited financial results for the first quarter ended June 30, 2024. It also mentions the closure of the trading window for insider trading compliance. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is a regulatory announcement about a future event (board meeting and financial results approval). The document length is only 1936 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2024-07-31 English
Board Meeting — GLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Comp…
Regulatory Filings
2024-07-31 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice from Glenmark Pharmaceuticals Limited addressed to stock exchanges about an upcoming Board Meeting scheduled for August 14, 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2024. It also mentions the closure of the trading window for insiders during this period. The document does not contain any financial data or results itself but is an announcement of the meeting where such results will be approved. The document length is short (1936 characters) and it serves as a notification rather than a report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to exchanges about board meetings and financial result approvals, not the financial report itself or a detailed interim report.
2024-07-31 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document contains multiple distinct sections. The first part is a letter addressed to stock exchanges regarding a newspaper advertisement for the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Authority, pursuant to SEBI regulations and the Companies Act. This is a regulatory announcement about share transfers to IEPF, not a financial report or detailed results. The letter references the publication of the notice in newspapers and on the company's website, indicating it is an announcement rather than a report itself. The document also includes extracts of financial results for various companies, such as standalone audited financial results for a quarter and year ended June 30, 2024, and unaudited financial results for a quarter ended June 30, 2024. These extracts are noted as being filed with stock exchanges and available on company websites. However, these appear as images or excerpts within the document and are not the full financial reports themselves. Given the document length (15,000 characters) and the nature of the content, the primary focus is the announcement of the newspaper advertisement for share transfer to IEPF Authority, which is a regulatory disclosure under SEBI Listing Obligations. The financial results excerpts are partial and do not constitute full financial reports. Therefore, the document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about share transfers to IEPF and includes some financial results excerpts but does not contain full financial statements or detailed financial analysis required for classifications like Annual Report (10-K) or Interim Report (IR).
2024-07-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.